ruthenium has been researched along with Neoplasms in 197 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (5.08) | 29.6817 |
| 2010's | 117 (59.39) | 24.3611 |
| 2020's | 63 (31.98) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Cheng, J; Hu, Y; Jiang, Z; Li, Y; Liu, M; Liu, Y; Qu, Y; Wang, H; Wang, W; Wang, Z; Wu, Y; Xiong, C; Xue, Z; Zhang, H; Zhao, Y; Zhou, F; Zhou, H; Zhu, X; Zhu, Y | 1 |
| Brindell, M; Gajda-Morszewski, P; Gurgul, I; Janczy-Cempa, E; Mazuryk, O | 1 |
| Chen, DS; Deng, H; Ding, Q; Gong, W; Gu, L; Gu, M; Guan, M; Hong, X; Li, Q; Liao, Y; Liu, Y; Lu, D; Pan, Y; Tian, Z; Wu, J; Xiao, Y; Xiong, X; Zhang, Z | 1 |
| Bo, H; Chen, D; Guo, S; Qiao, A; Rong, Y; Shen, H; Shen, J; Tang, X; Wang, J; Zhao, Z | 1 |
| Geisler, H; Harringer, S; Jakupec, MA; Kandioller, W; Keppler, BK; Urban, R; Wenisch, D | 1 |
| Banerjee, S | 1 |
| Li, ZY; Mao, ZW; Shen, QH; Tan, CP | 1 |
| Lai, Q; Lin, W; Lu, K; Mao, ZW; Tao, X; Wang, J; Xia, W; Xie, Y; Zhao, Z | 1 |
| Balakrishnan, A; Dhanapal, AR; Durairaju, N; Infanta S, AKT; Jayaraman, A; Murugesan, T; Muthusamy, P; Natarajan, K; Raja, S; Vedagiri, H | 1 |
| Bai, S; Fan, Y; Guan, X; Li, C; Ma, X; Sun, Y; Yang, J | 1 |
| El-Khamisy, SF; Liao, C; Lyon, RF; Poole, RK; Southam, HM; Trevitt, CR; Williamson, MP | 1 |
| Chao, H; Chen, X; Chen, Y; Ji, L; Karges, J; Lin, X; Liu, J; Ouyang, C; Wan, J; Xiong, K | 1 |
| Fenton, A; Glazer, EC; Hachey, AC; Havrylyuk, D; Heidary, DK | 1 |
| Brindell, M; Gros, PC; Gurgul, I; Lekka, M; Mazuryk, O; Olszanecki, R; Stachyra, K; Suzenet, F; Łomzik, M | 1 |
| Bai, S; Li, C; Liu, C; Sun, Y; Tu, L; Xiong, X; Xu, L; Yang, J; Zhang, X | 1 |
| Brindell, M; Gros, PC; Gurgul, I; Janczy-Cempa, E; Lekka, M; Mazuryk, O; Suzenet, F; Łomzik, M | 1 |
| Alessio, E; Burckel, P; Gandioso, A; Gasser, G; Vidal, A | 1 |
| Huang, J; Liu, J; Liu, Y | 1 |
| Batista, AA; Cominetti, MR; Correa, RS; de Oliveira, KM; Ellena, J; Godoy, LR; Graminha, AE; Honorato de Araujo-Neto, J; Popolin, C; Vegas, LC | 1 |
| Hangan, AC; Lucaciu, RL; Oprean, LS; Sevastre, B | 1 |
| Bonnet, S; Götzfried, SK; Husiev, Y; Klein, DM; Popal, S; Salitra, N; Schneider, GF; Siegler, MA; Van der Griend, CJ; van Geest, EP; Zhou, X | 1 |
| Fuster, MG; García, G; Montalbán, MG; Moulefera, I; Pérez, J; Víllora, G | 1 |
| Dominguez-Jurado, E; Gasser, G; Gois, PMP; Karges, J; Saubaméa, B; Silva, MJSA; Tharaud, M; Vinck, R; Wang, Y | 1 |
| Hong, Y; Khine, YY; Lu, H; Lu, M; Stenzel, MH; Wang, S; Zheng, J | 1 |
| Etchenique, R; Filevich, O | 1 |
| Enyedy, ÉA; Kovács, H; May, NV; Nezafat Yazdi, Z; Özvegy-Laczka, C; Pivarcsik, T; Pósa, SP; Pósa, V; Spengler, G; Szakács, G; Szatmári, I; Tóth, S; Ugrai, I | 1 |
| Chen, C; Lv, H; Shen, C; Xu, H; Zhu, D | 1 |
| Grishina, M; Kumar Singh, A; Kumar, A; Kumar, P; Pal Yadav, J; Pathak, P; Singh, H; Sonawane, P; Verma, A | 1 |
| Du, J; Fan, J; He, G; He, M; Hu, H; Li, X; Lu, Y; Peng, X; Sun, W; Wang, D; Wang, R; Wang, Z; Xu, N | 1 |
| Banerjee, S; Fan, Z; Huang, H; Kushwaha, R; Li, W; Liang, S; Mandal, AA; Wei, L; Xie, J | 1 |
| Budzisz, E; Hikisz, P; Namiecińska, E; Paneth, P | 1 |
| Balcerzak, Ł; Bryszewska, M; de la Mata, FJ; Garaiova, Z; Grodzicka, M; Hianik, T; Hołota, M; Ionov, M; Kubczak, M; Michlewska, S; Naziris, N; Okła, E; Ortega, P; Šubjakova, V; Waczulikova, I | 1 |
| Dharmasivam, M; Dorairaj, DP; Echeverria, C; Haribabu, J; Karvembu, R; Malekshah, RE; Mohamed Subarkhan, MK | 1 |
| Chen, J; Hu, H; Huang, C; Liang, L; Liu, H; Liu, Y; Wang, Y; Yang, Y; Zhang, H | 1 |
| Burke, CS; Curley, RC; Gkika, KS; Keyes, TE; Noorani, S; Walsh, N | 1 |
| Arnoux, P; Bosch, M; Burckel, P; Demeubayeva, N; Frochot, C; Gandioso, A; Gasser, G; Izquierdo-García, E; Marchán, V; Mesdom, P; Saubaméa, B | 1 |
| Cariou, K; Dömötör, O; Enyedy, ÉA; Gasser, G; Guérineau, V; Jakubaszek, M; Karges, J; Mignet, N; Seguin, J; Tharaud, M; Vinck, R | 1 |
| Das, S; Dinda, R; Patra, SA; Sahu, G | 1 |
| Bonnet, S | 1 |
| Chen, X; Liu, Z; Ma, W; Tian, Z; Xia, X; Xu, Z; Zhang, S; Zhang, Y | 1 |
| Aranđelović, S; Dojčinović, B; Gligorijević, N; Kaczmarek, AM; Radulović, S; Savić, A; Van Deun, R; Van Hecke, K | 1 |
| Bai, L; Du, F; Gu, YY; He, M; Jiang, GB; Wang, YJ; Yi, QY; Zhang, WY | 2 |
| Dyson, PJ; Murray, BS | 1 |
| Li, YH; Liu, JG; Shi, SW; Yang, SP; Zhang, QL | 1 |
| Pawlukojć, A; Piotrowski, M; Zuba, I; Zuba, M | 1 |
| Chao, H; Ji, L; Jin, C; Kuang, S; Liao, X; Liu, J; Xiong, K | 1 |
| Blower, TR; Cross, JM; Kingdon, ADH; Pal, R; Picton, DM; Walton, JW | 1 |
| P K, A; Paira, P | 1 |
| Baldari, S; Cirone, M; Crispini, A; D'Orazi, G; D'Orazi, V; Garufi, A; Gilardini Montani, MS; Giorno, E; Marchetti, F; Pettinari, R; Pistritto, G; Toietta, G | 1 |
| Ahmad, H; Gill, MR; Yusoh, NA | 1 |
| Hao, X; Liu, J; Qiu, K; Wang, J; Zhao, Z | 1 |
| Bai, Y; Chen, Y; Chen, Z; Fang, H; Guo, Z; Han, Z; He, W; Shi, X; Wang, Y; Yuan, H | 1 |
| Gasser, G; Soliman, N; Thomas, CM | 1 |
| Allison, M; Caramés-Méndez, P; Lord, RM; McGowan, PC; Pask, CM; Phillips, RM | 1 |
| Batista, AA; Cominetti, MR; Correa, RS; Demidoff, FC; Honorato, J; Netto, CD; Oliveira, KM; Schultz, MS | 1 |
| Chao, H; Gasser, G; Karges, J; Li, J; Zeng, L | 1 |
| Kim, CY; Lee, SY; Nam, TG | 1 |
| Alessio, E; Balducci, G; Duan, F; Giacomelli, C; La Mendola, D; Marchetti, F; Marchetti, L; Marzo, T; Messori, L; Pettinari, R; Tombesi, A; Trincavelli, ML; Zhou, L | 1 |
| Arlt, S; Eichhorn, T; Kaluđerović, GN; Lang, H; Ludwig, G; Maksimović-Ivanić, D; Mijatović, S; Petković, V; Rüffer, T | 1 |
| Gasser, G; Karges, J; Tharaud, M | 1 |
| Chen, F; He, M; Shao, D; Sun, W; Wei, Z; Weis, P | 1 |
| Mai Le, NP; Mo, J; Priefer, R | 1 |
| Huang, C; Huang, H; Liang, C; Luo, S; Xie, J; Zhang, P; Zhang, Q | 1 |
| Chan, L; Chen, T; Deng, Z; Gao, P; Ma, B; Mei, C; You, Y; Yu, L | 1 |
| Diserens, G; Furrer, J; Vermathen, M; Vermathen, P | 1 |
| Kim, S; Thangavel, P; Viswanath, B | 1 |
| Bugarčić, ŽD; Lazarević, T; Rilak, A | 1 |
| Accardo, A; Morelli, G; Ringhieri, P | 1 |
| Bratsos, I; Bugarčić, ŽD; Čanović, P; Demitri, N; Mitrović, M; Radisavljević, S; Simović, AR; Zelen, I | 1 |
| Batista, AA; Cominetti, MR; Corrêa, RS; Deflon, VM; Liany, LD; Oliveira, KM | 1 |
| Chen, G; Liu, J; Sun, J; Xu, M; Yu, Q; Zhao, S | 1 |
| Ahsan, H; Ali, SS; Khan, FH; Rehman, AA; Siddiqui, T; Zia, MK | 1 |
| Gasser, G; Notaro, A | 1 |
| Berger, W; Gerner, C; Hartinger, CG; Keppler, BK; Meier-Menches, SM | 1 |
| Sun, W; Wu, S; Zeng, X | 1 |
| De, S; Jacob, R; Maiti, S; Mondal, A; Moorthy, A; Paira, P; Sarkar, B; Sk, AK | 1 |
| Hanif, M; Hartinger, CG | 1 |
| Collins, KA; Kodanko, JJ; Rohrabaugh, TN; Turro, C; White, JK; Xue, C | 1 |
| Bai, Y; Cadavid-Vargas, JF; Etcheverry, SB; He, W; Kljun, J; León, IE; Peršič, Š; Turel, I | 1 |
| Ang, WH; Babak, MV; Cheong, MC; Chow, MJ; Gaiddon, C; Pastorin, G; Tan, KW | 1 |
| Bandow, JE; Cheng, X; Dabiri, Y; Hager, L; Keppler, BK; Ott, I; Prochnow, P; Streciwilk, W; Terenzi, A; Wölfl, S | 1 |
| Chapman, JA; Cox, FL; El-Khamisy, SF; Henderson, PJF; Hippler, M; Liao, C; Lyon, RL; Middlemiss, LA; Poole, RK; Smith, TW; Southam, HM; Trevitt, CR; Williamson, MP | 1 |
| Glazer, EC; Havrylyuk, D; Heidary, DK; Howerton, BS; Nease, L; Parkin, S | 1 |
| Brewer, KJ; Rodríguez-Corrales, JÁ; Wang, J; Winkel, BSJ | 1 |
| Cao, JJ; Ji, LN; Mao, ZW; Tan, CP; Zhang, DY; Zhang, H; Zheng, Y | 1 |
| Cameron, CG; Colón, KL; Gujar, S; Konda, P; Lilge, L; McFarland, SA; Monro, S; Roque, J; Thummel, RP; Yin, H | 1 |
| Guo, Z; Jin, S; Muhammad, N; Wang, X | 1 |
| Ferrari, S; Gasser, G; Goud, B; Jakubaszek, M | 1 |
| Chen, T; Li, CE; Zhang, X; Zhao, Z | 1 |
| Kenny, RG; Marmion, CJ | 1 |
| Casari, I; Desai, NM; Falasca, M; Massi, M; Simpson, PV | 1 |
| Guo, X; Hou, Y; Li, C; Lu, J; Sun, W; Tian, N; Wang, X; Zhou, Q | 1 |
| Cao, C; Ding, R; Li, X; Shi, Y; Stang, PJ; Teng, M; Zhang, L; Zhang, P; Zhao, Y | 1 |
| Chen, Y; Fu, HG; Liu, Y; Yu, Q | 1 |
| Di Virgilio, AL; Kljun, J; León, IE; Ruiz, MC; Turel, I | 1 |
| Dou, YK; He, XW; Li, WY; Li, YH; Shang, Y; Zhang, YK | 1 |
| Makovec, T | 1 |
| Dyson, PJ | 1 |
| Chen, T; Guo, Z; Huang, RT; Jiang, BP; Liang, H; Lu, Y; Shen, XC; Wang, WL; Wen, C; Zhou, B | 1 |
| Du, Q; Ge, X; Guo, L; Liu, X; Liu, Z; Tian, Z; Zhang, F; Zhao, L | 1 |
| Arjmand, F; Parveen, S; Tabassum, S | 1 |
| Beckford, FA; Fast, OG; Gentry, B; Niece, MB; Shell, SM; Strouth, L | 1 |
| Gasser, G; Goud, B; Jakubaszek, M; Karges, J; Mari, C; Stephan, H; Zarschler, K | 1 |
| Cong, H; Liu, D; Lv, F; Shen, Y; Yu, B; Zhang, X | 1 |
| Chen, S; Chen, T; Chen, Y; Fan, C; Liu, C; Mei, W; Wang, B; Wu, Q; Zheng, W | 1 |
| Therrien, B | 1 |
| Aleksenko, SS; Foteeva, LS; Jarosz, M; Lu, X; Matczuk, M; Pawlak, K; Timerbaev, AR | 1 |
| Chao, H; Chen, Y; Ji, LN; Qin, MY; Wang, L; Xu, AL | 1 |
| Aitken, JB; Antony, S; Brown, T; Harris, HH; Lai, B; Spiccia, L; Vogt, S | 1 |
| Huang, HL; Jiang, GB; Liang, ZH; Lin, GJ; Liu, YJ; Xie, YY | 1 |
| D'Errico, G; Irace, C; Mangiapia, G; Montesarchio, D; Musumeci, D; Paduano, L; Santamaria, R; Vitiello, G | 1 |
| Gupta, G; Johnpeter, JP; Kumar, JM; Nagesh, N; Srinivas, G; Therrien, B | 1 |
| Liu, J; Qin, X; Wang, C; Yang, L; Yu, Q; Zhang, J; Zhou, Y | 1 |
| da Silva, RS; Fukuto, JM; Heinrich, TA; Tedesco, AC | 1 |
| Kumar, YP; Nambigari, N; Reddy, MR; Reddy, PV; Satyanarayana, S; Srishailam, A | 1 |
| Chi, KW; Jeong, YJ; Jo, JH; Kang, SC; Lah, MS; Mishra, A | 1 |
| Li, ZS; Liu, P; Song, XM; Wang, KZ; Zhang, AG; Zhao, XL | 1 |
| Huang, Y; Liu, J; Liu, Y; Sun, J; Zheng, C; Zhou, Y | 1 |
| Hara, D; Ito, T; Kawasaki, A; Son, A; Tanabe, K | 1 |
| Cao, W; Chen, T; Deng, Z; Yu, L; Zheng, W | 1 |
| Brindell, M; Kieda, C; Mazuryk, O; Suzenet, F | 1 |
| Clavel, CM; Dyson, PJ; Griffioen, AW; Nowak-Sliwinska, P; Păunescu, E; Scopelliti, R | 1 |
| Allison, SJ; Hebden, AJ; Henderson, IR; Lord, RM; McGowan, PC; Pask, CM; Phillips, RM; Shepherd, SL | 1 |
| Bhavsar, D; Chen, LM; Chen, Q; Liu, J; Liu, Y; Ren, X; Sun, D; Yang, L; Yu, Q; Zheng, W | 1 |
| Arcangeli, A; Contel, M; Fernández-Gallardo, J; Guerri, A; Massai, L; Messori, L; Pillozzi, S | 1 |
| Diserens, G; Furrer, J; Paul, LE; Vermathen, M; Vermathen, P | 1 |
| Liu, S; Luo, Q; Wang, F; Zhang, E; Zhang, Y; Zhao, Y; Zheng, W | 1 |
| Fischer, S; Lamla, M; Monczak, K; Ng, DY; Rau, S; Wang, T; Weil, T; Wu, Y; Zabarska, N | 1 |
| Chen, H; Dong, L; Ge, X; Huang, W; Jin, D; Li, N; Ma, B; Shi, L; Sun, L | 1 |
| Chao, H; Chen, Y; Huang, H; Ji, L; Zhang, P | 1 |
| Bergamo, A; Brescacin, L; Masi, A; Sava, G | 1 |
| Ding, Y; Mei, W; Wu, Q; Zheng, K | 1 |
| Abid, M; Azam, A; Shamsi, F | 1 |
| Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Cheminel, T; Grozav, A; Therrien, B | 1 |
| Jia, J; Liu, P; Wang, KZ; Zhao, Y | 1 |
| Elmes, RB; Gunnlaugsson, T; la Cour Poulsen, B; Martínez-Calvo, M; Orange, KN; Williams, DC | 1 |
| Butt, HJ; Mailänder, V; Parowatkin, M; Steffen, W; Sun, W; Wu, S | 1 |
| Ajibade, PA; Ejidike, IP | 1 |
| Brustolin, L; Fregona, D; Nardon, C | 1 |
| Cao, DH; Guo, QF; Liang, JB; Lin, YY; Liu, SH; Liu, YM; Wang, Y; Wu, Y; Xu, HH; Zhang, GQ; Zhu, JW | 1 |
| Garcia, MH; Marques, F; Morais, TS; Tomaz, AI; Valente, A | 1 |
| Thota, S | 1 |
| Li, P; Su, W; Tang, Z | 1 |
| Biersack, B | 1 |
| de França Lopes, LG; Gouveia, FS; Ridnour, LA; Sadler, PJ; Silva da Silva, CD; Silva Sousa, EH; Wink, DA | 1 |
| Chao, H; Ji, L; Qian, C; Wu, J | 1 |
| Mei, W; Tan, W; Wang, C; Wu, Q; Zheng, K | 1 |
| Barbosa, MI; Batista, AA; Carnizello, AP; Ferreira, NH; Magalhães, GM; Martins, M; Oliveira, PF; Tavares, DC | 1 |
| Li, N; Mou, Z; Sun, D; Wang, W; Wang, Y; Yang, E; Zhang, W | 1 |
| Gobec, S; Kljun, J; Kos, J; Mitrović, A; Sosič, I; Turel, I | 1 |
| Butt, HJ; Häupler, B; Jin, S; Li, S; Liang, XJ; Liu, J; Schubert, US; Steffen, W; Sun, W; Wu, S | 1 |
| Ali, M; Armant, O; Capuozzo, A; Cianferani, S; Delalande, F; Gaiddon, C; Licona, C; Mellitzer, G; Pfeffer, M; Santamaria, R; Spaety, ME; Spencer, J; Van Dorsselaer, A | 1 |
| Cheah, KW; Chelora, J; Chen, R; Kershaw, SV; Lee, CS; Li, KF; Lo, PK; Rogach, AL; Xiong, Y; Zapien, JA; Zhang, J | 1 |
| Cao, R; He, N; Huang, FY; Huang, J; Lu, Z; Tan, GH; Wang, G; Zhang, L; Zhang, Z | 1 |
| Prudhomme, M | 1 |
| Fry, NL; Hinck, L; Marlow, R; Mascharak, PK; Rose, MJ | 1 |
| Brabec, V; Bugarcic, T; Habtemariam, A; Halámiková, A; Kaspárková, J; Nováková, O; Parsons, S; Sadler, PJ; Vrána, O; Zerzánková, L | 1 |
| Govindaswamy, P; Juillerat-Jeanneret, L; Schmitt, F; Süss-Fink, G; Therrien, B; Zava, O | 1 |
| Ford, PC; Ostrowski, AD | 1 |
| Fregona, D; Ronconi, L | 1 |
| Arion, VB; Gligorijević, N; Grgurić-Sipka, S; Ivanović, I; Keppler, BK; Radulović, S; Rakić, G; Tesić, ZLj; Todorović, N | 1 |
| Dyson, PJ; Renfrew, AK; Scopelliti, R | 1 |
| Silva, Dde O | 1 |
| Bi, S; Hao, S; Li, L; Zhang, S | 1 |
| Ducani, C; Hannon, MJ; Hodges, NJ; Leczkowska, A | 1 |
| Fry, NL; Heilman, BJ; Mascharak, PK | 1 |
| Barker, PD; Boss, SR; Page, SM | 1 |
| León, LG; Lorenzo-Luis, P; Mena-Cruz, A; Padrón, JM; Pérez-Roth, E; Ríos-Luci, C; Romerosa, A | 1 |
| Barragán, F; Betanzos-Lara, S; Habtemariam, A; López-Senín, P; Marchán, V; Moreno, V; Sadler, PJ; Salassa, L | 1 |
| Bogdanović, A; Dulović, M; Grgurić-Šipka, S; Jovanović, M; Marković, I; Misirlić-Denčić, S; Poljarević, JM; Sabo, TJ; Savić, A; Trajković, V | 1 |
| Smith, GS; Therrien, B | 1 |
| Alborzinia, H; Baumann, K; Ludewig, S; Oehninger, L; Ott, I; Wölfl, S | 1 |
| Maresca, A; Poulsen, SA; Salmon, AJ; Supuran, CT; Williams, ML | 1 |
| Furrer, J; Giannini, F; Süss-Fink, G | 1 |
| Dyson, PJ; Groessl, M | 1 |
| Hartinger, CG; Nazarov, AA; Phillips, AD | 1 |
| Beijnen, JH; Bergamo, A; Gaiddon, C; Sava, G; Schellens, JH | 1 |
| Barry, NP; Juillerat-Jeanneret, L; Schmitt, F; Therrien, B | 1 |
| Colonna, A; D'Errico, G; Di Pascale, A; Irace, C; Mangiapia, G; Montesarchio, D; Paduano, L; Radulescu, A; Simeone, L | 1 |
| Jin, L; Liu, J; Shen, J; Tan, L; Weng, C; Zeng, L | 1 |
| Glazer, EC; Heidary, DK; Howerton, BS | 1 |
| Fregona, D; Nagy, EM; Nardon, C; Ronconi, L | 1 |
| Cao, W; Chen, T; Fan, C; Li, L; Zheng, W | 1 |
| Angeletti, M; Bonfili, L; Cecarini, V; Cuccioloni, M; Eleuteri, AM; Lupidi, G; Marchetti, F; Mozzicafreddo, M; Pettinari, C; Pettinari, R | 1 |
| Downward, AM; Hartshorn, RM; Jane, RT; Moore, EG; Polson, MI | 1 |
| FRUIN, RC; LITTMAN, A; LITTMAN, MS | 1 |
| ALTSHULER, B; DANIELS, M; HARLEY, JH; KUSCHNER, M; LASKIN, S; NELSON, N | 1 |
| ALTSHULER, B; KUSCHNER, M; LASKIN, S; NELSON, N | 1 |
| DWYER, FP; MAYHEW, E; ROE, EM; SHULMAN, A | 1 |
| Alessio, E; Bergamo, A; Casarsa, C; Cocchietto, M; Sava, G; Serli, B; Stocco, G; Zorzet, S | 1 |
| Cocchietto, M; Frausin, F; Furlani, A; Podda, E; Sava, G; Scarcia, V; Spessotto, P; Vita, F; Zabucchi, G | 1 |
| Groessl, M; Hann, S; Hartinger, CG; Keppler, BK; Koellensperger, G; Rudnev, AV; Stingeder, G; Sulyok, M; Timerbaev, AR | 1 |
| Aleksenko, SS; Hartinger, CG; Keppler, BK; Timerbaev, AR | 1 |
| Anghileri, LJ | 1 |
| Wenzel, M | 1 |
| Rudolph, R | 1 |
44 review(s) available for ruthenium and Neoplasms
| Article | Year |
|---|---|
Moving Ru polypyridyl complexes beyond cytotoxic activity towards metastasis inhibition.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Coordination Complexes; Humans; Neoplasm Metastasis; Neoplasms; Pyridines; Ruthenium | 2022 |
Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Immunotherapy; Iridium; Neoplasms; Ruthenium | 2022 |
Metallo-Drugs in Cancer Therapy: Past, Present and Future.
Topics: Antineoplastic Agents; Coordination Complexes; Copper; Humans; Neoplasms; Platinum; Ruthenium | 2022 |
Metal Complexes in Cancer Treatment: Journey So Far.
Topics: Antineoplastic Agents; Cisplatin; Coordination Complexes; Humans; Neoplasms; Ruthenium | 2023 |
Recent Advances in Mitochondria-Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Mitochondria; Neoplasms; Ruthenium | 2023 |
Ruthenium-Based Photoactivated Chemotherapy.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2023 |
Recent progress in the development of organometallics for the treatment of cancer.
Topics: Animals; Antineoplastic Agents; Chromatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Gold; Humans; Models, Molecular; Neoplasms; Organometallic Compounds; Photochemotherapy; Platinum; Ruthenium; Silver | 2020 |
Ruthenium as an important element in nuclear energy and cancer treatment.
Topics: Humans; Neoplasms; Nuclear Energy; Radioisotopes; Ruthenium | 2020 |
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy.
Topics: Antineoplastic Agents; Coordination Complexes; Gold; Humans; Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Ruthenium | 2020 |
Incorporation of Ru(II) Polypyridyl Complexes into Nanomaterials for Cancer Therapy and Diagnosis.
Topics: Animals; Coordination Complexes; Humans; Nanomedicine; Nanostructures; Neoplasms; Pyridines; Ruthenium | 2020 |
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2020 |
Photoresponsive metallopolymer nanoparticles for cancer theranostics.
Topics: Humans; Nanoparticles; Neoplasms; Phototherapy; Precision Medicine; Ruthenium | 2021 |
Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2021 |
Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.
Topics: Antineoplastic Agents; Drug Delivery Systems; Humans; Ligands; Nanostructures; Neoplasms; Photochemotherapy; Ruthenium; Ruthenium Compounds | 2017 |
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Drug Discovery; Gold; Humans; Neoplasms; Palladium; Platinum; Ruthenium | 2017 |
Supramolecular Delivery Systems for Non-Platinum Metal-Based Anticancer Drugs.
Topics: Antineoplastic Agents; Cisplatin; Coordination Complexes; Neoplasms; Ruthenium | 2017 |
Chemotherapeutic Drugs and Plasma Proteins: Exploring New Dimensions.
Topics: Antineoplastic Agents; Blood Proteins; Cell Survival; Cisplatin; Coordination Complexes; Fluorouracil; Humans; Neoplasms; Platinum; Ruthenium | 2018 |
Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; Coordination Complexes; Humans; Neoplasms; Pyridines; Ruthenium | 2017 |
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.
Topics: Antineoplastic Agents; Cell Proliferation; Humans; Neoplasms; Organometallic Compounds; Osmium; Ruthenium; Structure-Activity Relationship | 2018 |
Photoresponsive ruthenium-containing polymers: potential polymeric metallodrugs for anticancer phototherapy.
Topics: Neoplasms; Organometallic Compounds; Photosensitizing Agents; Phototherapy; Ruthenium | 2018 |
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.
Topics: Clinical Trials as Topic; Coordination Complexes; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium; Transition Elements | 2019 |
Stimuli-Responsive Therapeutic Metallodrugs.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Hydrogen-Ion Concentration; Light; Neoplasms; Oxidation-Reduction; Platinum; Ruthenium; Temperature | 2019 |
Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Humans; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polymers; Pyridines; Ruthenium | 2018 |
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Topics: ATP-Binding Cassette Transporters; Coordination Complexes; DNA Damage; Enzymes; Humans; Neoplasms; Platinum; Prodrugs; Ruthenium | 2019 |
Metal-based antitumor compounds: beyond cisplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Copper; Drug Discovery; Gold; Humans; Iridium; Iron; Metals; Neoplasms; Organometallic Compounds; Rhenium; Rhodium; Ruthenium | 2019 |
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy.
Topics: Antineoplastic Agents; Cisplatin; DNA Adducts; DNA Repair; DNA, Neoplasm; Drug Hypersensitivity; Drug Resistance, Neoplasm; Gold Compounds; Humans; Neoplasms; Organometallic Compounds; Palladium; Platinum Compounds; Polymorphism, Genetic; Ruthenium | 2019 |
Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line; Cell Line, Tumor; DNA Topoisomerases; ErbB Receptors; Gold; Humans; Neoplasms; Nucleic Acids; Organometallic Compounds; Ruthenium; Thioredoxin-Disulfide Reductase; Titanium; Transferrin | 2019 |
Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Humans; Mice; Molecular Structure; Neoplasms; Platinum; Ruthenium; Xenograft Model Antitumor Assays | 2019 |
Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Coordination Complexes; Humans; Hydrocarbons, Aromatic; Neoplasm Invasiveness; Neoplasms; Ruthenium | 2016 |
Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; DNA; DNA Damage; Drug Discovery; Humans; Neoplasms; Ruthenium | 2016 |
Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Dimethyl Sulfoxide; DNA; Humans; Imidazoles; Light; Models, Molecular; Neoplasms; Organometallic Compounds; Ruthenium; Ruthenium Compounds | 2016 |
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Coordination Complexes; Dimethyl Sulfoxide; Humans; Ligands; Neoplasms; Organometallic Compounds; Ruthenium; Ruthenium Compounds | 2016 |
Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Cyclopentanes; Dimethyl Sulfoxide; Drug Discovery; Ferrous Compounds; Humans; Indazoles; Molecular Targeted Therapy; Neoplasms; Organometallic Compounds; Protein Binding; Ruthenium; Ruthenium Compounds | 2016 |
Development of Arene Ruthenium Antitumor Complexes.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Drug Discovery; Humans; Hydrocarbons, Aromatic; Neoplasms; Ruthenium | 2016 |
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; DNA; Drug Discovery; Humans; Hydrocarbons, Aromatic; Ligands; Neoplasms; Ruthenium | 2016 |
Ruthenium(II) Complexes as Potential Apoptosis Inducers in Chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Coordination Complexes; DNA Damage; Drug Discovery; Endoplasmic Reticulum Stress; G-Quadruplexes; Humans; Mitochondria; Neoplasms; Ruthenium; Signal Transduction | 2017 |
Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Dimethyl Sulfoxide; Glioblastoma; Humans; Indazoles; Ligands; Neoplasms; Organometallic Compounds; Organoplatinum Compounds; Rats; Ruthenium; Ruthenium Compounds; Solubility | 2010 |
Tuning heavy metal compounds for anti-tumor activity: is diversity the key to ruthenium's success?
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Neoplasms; Platinum; Ruthenium | 2009 |
Targeted and multifunctional arene ruthenium chemotherapeutics.
Topics: Cell Proliferation; Coordination Complexes; Humans; Neoplasms; Photosensitizing Agents; Porphyrins; Ruthenium | 2011 |
Bioanalytical and biophysical techniques for the elucidation of the mode of action of metal-based drugs.
Topics: Antineoplastic Agents; Chemistry Techniques, Analytical; DNA; Drug Delivery Systems; Gallium; Gold; Humans; Microscopy, Fluorescence; Neoplasms; Organometallic Compounds; Proteins; Ruthenium; Titanium | 2011 |
Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics.
Topics: Antineoplastic Agents; Coordination Complexes; Cross-Linking Reagents; DNA; Enzyme Inhibitors; Gold; Humans; Models, Molecular; Neoplasms; Organometallic Compounds; Osmium; Photochemical Processes; Ruthenium | 2011 |
Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates.
Topics: Animals; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Organometallic Compounds; Ruthenium | 2012 |
Noble metal-dithiocarbamates precious allies in the fight against cancer.
Topics: Antineoplastic Agents; Apoptosis; Coordination Complexes; Copper; Gold; Humans; Neoplasms; Palladium; Platinum; Ruthenium; Thiocarbamates | 2012 |
Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.
Topics: Animals; Antineoplastic Agents; Binding Sites; Blood Proteins; Cisplatin; Drug Interactions; Electrophoresis, Gel, Two-Dimensional; Humans; Neoplasms; Protein Binding; Protein Conformation; Ruthenium; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Structure-Activity Relationship | 2006 |
153 other study(ies) available for ruthenium and Neoplasms
| Article | Year |
|---|---|
Biocompatible Ruthenium Single-Atom Catalyst for Cascade Enzyme-Mimicking Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbon; Catalysis; Cell Line, Tumor; Glutathione; Hydrogen Peroxide; Kinetics; Mice; Neoplasms; Oxidation-Reduction; Oxidative Stress; Quantum Dots; Ruthenium | 2021 |
A Second Near-Infrared Ru(II) Polypyridyl Complex for Synergistic Chemo-Photothermal Therapy.
Topics: Apoptosis; Biocompatible Materials; Cell Line, Tumor; Coordination Complexes; Drug Design; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Humans; Hyperthermia, Induced; Infrared Rays; Neoplasms; Phenazines; Photothermal Therapy; Polyethylene Glycols; Quantum Theory; Ruthenium; Spectroscopy, Near-Infrared | 2022 |
Combination of ruthenium (II) polypyridyl complex Δ-Ru1 and Taxol enhances the anti-cancer effect on Taxol-resistant cancer cells through Caspase-1/GSDMD-mediated pyroptosis.
Topics: Animals; Caspase 1; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Mice; Neoplasms; Paclitaxel; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Pyroptosis; Ruthenium | 2022 |
Systematic Study on the Cytotoxic Potency of Commonly Used Dimeric Metal Precursors in Human Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Iridium; Neoplasms; Osmium; Rhodium; Ruthenium | 2022 |
Metal-based Complexes as Potential Anti-cancer Agents.
Topics: Antineoplastic Agents; Cisplatin; Coordination Complexes; Humans; Neoplasms; Platinum; Ruthenium | 2022 |
In Situ Prodrug Activation by an Affibody-Ruthenium Catalyst Hybrid for HER2-Targeted Chemotherapy.
Topics: Catalysis; Humans; Neoplasms; Prodrugs; Ruthenium | 2022 |
Pharmacological assessment of Ru(II) complex with GidA protein- A novel topoisomerase II inhibitor towards cancer therapeutics.
Topics: DNA Topoisomerases, Type II; Humans; Molecular Docking Simulation; Neoplasms; Ruthenium; Staphylococcal Protein A; Topoisomerase II Inhibitors | 2023 |
NIR-II Emissive Ru(II) Metallacycle Assisting Fluorescence Imaging and Cancer Therapy.
Topics: Cisplatin; Neoplasms; Optical Imaging; Phototherapy; Ruthenium; Theranostic Nanomedicine | 2022 |
CORM-3 induces DNA damage through Ru(II) binding to DNA.
Topics: Antineoplastic Agents; DNA; DNA Damage; Humans; Neoplasms; Ruthenium | 2022 |
Chiral Ru
Topics: Animals; Antineoplastic Agents; Cisplatin; Coordination Complexes; DNA; G-Quadruplexes; Mice; Neoplasms; Ruthenium; Telomerase; Telomere | 2022 |
Ru(II) photocages enable precise control over enzyme activity with red light.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Neoplasms; Ruthenium | 2022 |
Impact of Polypyridyl Ru Complexes on Angiogenesis-Contribution to Their Antimetastatic Activity.
Topics: 2,2'-Dipyridyl; Coordination Complexes; Endothelial Cells; Humans; Ligands; Neoplasms; Phenanthrolines; Ruthenium | 2022 |
Rationally designed Ru(II) metallacycles with tunable imidazole ligands for synergistical chemo-phototherapy of cancer.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Imidazoles; Ligands; Neoplasms; Phototherapy; Ruthenium | 2022 |
Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion -
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Cell Adhesion; Coordination Complexes; Humans; Ligands; Neoplasms; Ruthenium | 2022 |
Ruthenium(II) Polypyridyl Complexes Containing Simple Dioxo Ligands: a Structure-Activity Relationship Study Shows the Importance of the Charge.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Coordination Complexes; Humans; Ligands; Malonates; Neoplasms; Oxalates; Platinum; Ruthenium; Structure-Activity Relationship | 2022 |
Single laser activated photothermal/photodynamic dual-modal cancer phototherapy by using ROS-responsive targeting flower-like ruthenium nanoparticles.
Topics: Humans; Lasers; Nanoparticles; Neoplasms; Oxides; Photochemotherapy; Phototherapy; Reactive Oxygen Species; Ruthenium | 2022 |
New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.
Topics: Aminosalicylic Acid; Amobarbital; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Humans; Neoplasms; Phosphorus; Ruthenium; Salicylic Acid | 2022 |
A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Neoplasms; Prodrugs; Ruthenium | 2023 |
Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Humans; Neoplasms; Ruthenium | 2022 |
Towards Selective Delivery of a Ruthenium(II) Polypyridyl Complex-Containing Bombesin Conjugate into Cancer Cells.
Topics: Antineoplastic Agents; Bombesin; Coordination Complexes; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2023 |
Dual drug delivery system of RAPTA-C and paclitaxel based on fructose coated nanoparticles for metastatic cancer treatment.
Topics: Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Fructose; Humans; Micelles; Nanoparticles; Neoplasms; Paclitaxel; Polymers; Ruthenium; Tissue Distribution | 2023 |
Shine, Shine, Ruthenium Caged Drug.
Topics: Antineoplastic Agents; Humans; Neoplasms; Pharmaceutical Preparations; Ruthenium | 2023 |
Metal Complexes of a 5-Nitro-8-Hydroxyquinoline-Proline Hybrid with Enhanced Water Solubility Targeting Multidrug Resistant Cancer Cells.
Topics: Antineoplastic Agents; Coordination Complexes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ferric Compounds; Ferrous Compounds; Humans; Ions; Ligands; Neoplasms; Organometallic Compounds; Proline; Ruthenium; Solubility; Water | 2022 |
Cyclometalated Ru(II)-NHC complexes with phenanthroline ligands induce apoptosis mediated by mitochondria and endoplasmic reticulum stress in cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Coordination Complexes; Endoplasmic Reticulum Stress; HeLa Cells; Humans; Ligands; Mitochondria; Neoplasms; Phenanthrolines; Ruthenium | 2023 |
A Near-Infrared Light-Activated Photocage Based on a Ruthenium Complex for Cancer Phototherapy.
Topics: Humans; Nanoparticles; Neoplasms; Photochemotherapy; Phototherapy; Polymers; Ruthenium | 2023 |
Anticancer Screening of Ru(II) Photoredox Catalysts at Single Cancer Cell Level.
Topics: Antineoplastic Agents; Cisplatin; Coordination Complexes; Early Detection of Cancer; Humans; Neoplasms; Ruthenium | 2023 |
Mechanistic Studies of Arene-Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Neoplasms; Reactive Oxygen Species; Ruthenium | 2023 |
Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols.
Topics: Antineoplastic Agents; Dendrimers; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Liposomes; Neoplasms; Ruthenium | 2023 |
Ru(II)-
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Cymenes; Ligands; Mice; Neoplasms; Ruthenium | 2023 |
Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Humans; Molecular Docking Simulation; Neoplasms; Phenanthrolines; Reactive Oxygen Species; RNA; Ruthenium | 2023 |
Phototoxicity of Tridentate Ru(II) Polypyridyl Complex with Expanded Bite Angles toward Mammalian Cells and Multicellular Tumor Spheroids.
Topics: Animals; CHO Cells; Coordination Complexes; Cricetinae; Cricetulus; Humans; Ligands; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2023 |
Ru(II)-Cyanine Complexes as Promising Photodynamic Photosensitizers for the Treatment of Hypoxic Tumours with Highly Penetrating 770 nm Near-Infrared Light.
Topics: Coloring Agents; Coordination Complexes; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2023 |
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Ligands; Maleimides; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium; Serum Albumin | 2023 |
Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Iridium; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Naphthalimides; Neoplasms; Ruthenium | 2019 |
Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cisplatin; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Neoplasms; Organometallic Compounds; Phenanthrolines; Ruthenium; Tumor Cells, Cultured | 2020 |
New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cattle; Cell Cycle Checkpoints; Coordination Complexes; DNA; Furans; Halogenation; Humans; Intercalating Agents; Membrane Potential, Mitochondrial; Neoplasms; Pyridines; Reactive Oxygen Species; Ruthenium | 2020 |
Targeted and NIR light-controlled delivery of nitric oxide combined with a platinum(iv) prodrug for enhanced anticancer therapy.
Topics: Drug Delivery Systems; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Nanoparticles; Neoplasms; Nitric Oxide; Phototherapy; Platinum Compounds; Prodrugs; Quantum Dots; Ruthenium | 2019 |
Boosting two-photon photodynamic therapy with mitochondria-targeting ruthenium-glucose conjugates.
Topics: Animals; Cell Line; Cell Survival; Glucose; Humans; Light; Mice, Inbred BALB C; Mitochondria; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium; Tumor Burden | 2020 |
Anticancer Ruthenium Complexes with HDAC Isoform Selectivity.
Topics: Cell Proliferation; Coordination Complexes; HeLa Cells; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Neoplasms; Protein Conformation; Protein Isoforms; Ruthenium; Ruthenium Compounds | 2020 |
Luminescent anticancer Ru(II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application.
Topics: Antineoplastic Agents; Coordination Complexes; DNA; HEK293 Cells; HeLa Cells; Humans; Luminescent Measurements; MCF-7 Cells; Neoplasms; Phenanthrolines; Pyridines; Ruthenium | 2020 |
Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; Humans; Neoplasms; Pyridines; Ruthenium | 2020 |
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Mutation; Neoplasms; NF-E2-Related Factor 2; Ruthenium; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2020 |
Two-photon photodynamic ablation of tumour cells using an RGD peptide-conjugated ruthenium(ii) photosensitiser.
Topics: Animals; Cell Line, Tumor; Coordination Complexes; Humans; Mice; Mice, Nude; Mitochondria; Neoplasms; Oligopeptides; Photochemotherapy; Photons; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium; Transplantation, Heterologous | 2020 |
Photoinduced synergistic cytotoxicity towards cancer cells
Topics: Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Ligands; MCF-7 Cells; Neoplasms; Phenanthrolines; Photochemotherapy; Pyridines; Ruthenium; Singlet Oxygen; Structure-Activity Relationship | 2020 |
Bis(bipyridine)ruthenium(II) Ferrocenyl β-Diketonate Complexes: Exhibiting Nanomolar Potency against Human Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Comet Assay; Coordination Complexes; Humans; Microbial Sensitivity Tests; Neoplasms; Ruthenium | 2021 |
Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; Humans; MCF-7 Cells; Naphthoquinones; Neoplasms; Phosphines; Ruthenium | 2021 |
Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Female; Humans; Light; Mice; Mice, Nude; Neoplasms; Photochemotherapy; Photons; Photosensitizing Agents; Polymers; Pyridines; Ruthenium; Singlet Oxygen; Spheroids, Cellular; Tissue Distribution; Transplantation, Heterologous | 2020 |
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity.
Topics: Alkanes; Antineoplastic Agents; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Curcumin; Humans; Models, Molecular; Neoplasms; Ruthenium; Sulfur Compounds; Tumor Cells, Cultured | 2021 |
Arene Ruthenium(II) Complexes Bearing the κ-
Topics: Antineoplastic Agents; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Neoplasms; Ruthenium | 2021 |
Polymeric Encapsulation of a Ru(II)-Based Photosensitizer for Folate-Targeted Photodynamic Therapy of Drug Resistant Cancers.
Topics: Cell Culture Techniques; Cell Line; Cell Survival; Coordination Complexes; Drug Resistance, Neoplasm; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Light; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polymers; Ruthenium; Singlet Oxygen; Spheroids, Cellular | 2021 |
A highly potent ruthenium(II)-sonosensitizer and sonocatalyst for in vivo sonotherapy.
Topics: Animals; Antineoplastic Agents; Humans; Mice; Mice, Inbred BALB C; NAD; Neoplasms; Oxidation-Reduction; Porphyrins; Ruthenium; Singlet Oxygen; Ultrasonic Therapy; Ultrasonic Waves | 2021 |
Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cisplatin; Coordination Complexes; DNA Damage; Endocytosis; Humans; Mice, Nude; Models, Biological; Neoplasms; Phosphorylation; Pyridines; Reactive Oxygen Species; Receptors, Death Domain; Receptors, Transferrin; Ruthenium; Spheroids, Cellular; Tissue Distribution; Tumor Suppressor Protein p53 | 2017 |
Metabolic Profiling of Cells in Response to Drug Treatment using
Topics: Amino Acids; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Resistance, Neoplasm; HEK293 Cells; Humans; Magnetic Resonance Spectroscopy; Metabolomics; Neoplasms; Principal Component Analysis; Ruthenium | 2017 |
Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Coordination Complexes; DNA; Humans; Models, Molecular; Neoplasms; Pyridines; Ruthenium; Serum Albumin, Bovine | 2017 |
Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; G1 Phase; Humans; Naphthoquinones; Neoplasms; Ruthenium; S Phase | 2017 |
Pompon-like RuNPs-Based Theranostic Nanocarrier System with Stable Photoacoustic Imaging Characteristic for Accurate Tumor Detection and Efficient Phototherapy Guidance.
Topics: Humans; Metal Nanoparticles; Neoplasms; Photoacoustic Techniques; Phototherapy; Ruthenium; Theranostic Nanomedicine | 2017 |
Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging.
Topics: Antineoplastic Agents; Binding Sites; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; HeLa Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Neoplasms; Oxyquinoline; Polystyrenes; Protein Binding; Ruthenium; Serum Albumin, Bovine; Structure-Activity Relationship; Water | 2018 |
Anticancer metallodrugs: where is the next cisplatin?
Topics: Antineoplastic Agents; Cisplatin; Coordination Complexes; Endoplasmic Reticulum Stress; Humans; Neoplasms; Platinum; Prodrugs; Ruthenium | 2018 |
New Ru(ii) complex for dual photochemotherapy: release of cathepsin K inhibitor and
Topics: Acetonitriles; Cathepsin K; Coordination Complexes; Enzyme Inhibitors; Humans; Ligands; Methanol; Neoplasms; Phenazines; Photochemotherapy; Photosensitizing Agents; Plasmids; Pyridines; Ruthenium; Singlet Oxygen; Water | 2018 |
Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines.
Topics: A549 Cells; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Humans; Neoplasms; Organometallic Compounds; Oxyquinoline; Ruthenium | 2018 |
Induction of the Endoplasmic Reticulum Stress Pathway by Highly Cytotoxic Organoruthenium Schiff-Base Complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Stress; Humans; Molecular Structure; Neoplasms; Organometallic Compounds; Quinolines; Reactive Oxygen Species; Ruthenium; Schiff Bases; Structure-Activity Relationship | 2018 |
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorescent Dyes; G-Quadruplexes; Humans; Intercalating Agents; Ligands; Naphthalimides; Neoplasms; Organometallic Compounds; Rhodium; Ruthenium | 2018 |
A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Carbon Monoxide; Cell Line, Tumor; Cell Survival; Escherichia coli; Escherichia coli Infections; Humans; Neoplasms; Organometallic Compounds; Ruthenium | 2018 |
Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Humans; Hydroxyquinolines; Ligands; Models, Molecular; Neoplasms; Protein Biosynthesis; Ruthenium; Structure-Activity Relationship; Transcription, Genetic | 2018 |
Mechanistic Investigation into DNA Modification by a Ru
Topics: Antineoplastic Agents; DNA; Humans; Light; Neoplasms; Oxygen; Photochemotherapy; Photolysis; Photosensitizing Agents; Rhodium; Ruthenium; Tumor Hypoxia | 2018 |
Photodamaging of Mitochondrial DNA to Overcome Cisplatin Resistance by a Ru
Topics: A549 Cells; Antineoplastic Agents; Cisplatin; Coordination Complexes; DNA Damage; DNA, Mitochondrial; HeLa Cells; Humans; Neoplasms; Organoplatinum Compounds; Phenanthrolines; Photochemotherapy; Photosensitizing Agents; Pyrimidines; Ruthenium | 2018 |
Designing luminescent ruthenium prodrug for precise cancer therapy and rapid clinical diagnosis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Luminescent Agents; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Optical Imaging; Prodrugs; Ruthenium; Theranostic Nanomedicine; Tumor Microenvironment | 2019 |
Mitochondria targeted and NADH triggered photodynamic activity of chloromethyl modified Ru(ii) complexes under hypoxic conditions.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Coordination Complexes; DNA Cleavage; Humans; Light; Membrane Potential, Mitochondrial; Mitochondria; NAD; Neoplasms; Photochemotherapy; Ruthenium | 2019 |
Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Imidazoles; MCF-7 Cells; Neoplasms; Ruthenium | 2019 |
A tumor-targeting Ru/polysaccharide/protein supramolecular assembly with high photodynamic therapy ability.
Topics: A549 Cells; Adamantane; beta-Cyclodextrins; Cell Line; Coordination Complexes; Drug Delivery Systems; Humans; Models, Molecular; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium; Transferrin | 2019 |
Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Humans; Models, Biological; Neoplasms; Organometallic Compounds; Oxyquinoline; Ruthenium; Ruthenium Compounds | 2019 |
Preparation of a Ruthenium-Complex-Functionalized Two-Photon-Excited Red Fluorescence Silicon Nanoparticle Composite for Targeted Fluorescence Imaging and Photodynamic Therapy in Vitro.
Topics: Animals; Cell Survival; Coordination Complexes; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Folic Acid; HeLa Cells; Humans; Mice; Mice, Nude; Microwaves; Nanoparticles; Neoplasms; Optical Imaging; Photochemotherapy; Ruthenium; Silicon; Singlet Oxygen; Toxicity Tests; Zebrafish | 2019 |
Ruthenium - A Non-essential Element that May Become Essential in Treating Chemoresistant Cancers.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Neoplasms; Ruthenium | 2019 |
Receptor-Mediated and Tumor-Microenvironment Combination-Responsive Ru Nanoaggregates for Enhanced Cancer Phototheranostics.
Topics: Animals; Apoptosis; Cell Line, Tumor; Contrast Media; Doxorubicin; Drug Delivery Systems; Humans; Hyaluronic Acid; Mice; Nanoparticles; Neoplasms; Photochemotherapy; Ruthenium; Theranostic Nanomedicine; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
Topics: A549 Cells; Amination; Antineoplastic Agents; Cell Survival; Coordination Complexes; Crystallography, X-Ray; HeLa Cells; Hep G2 Cells; Humans; Imines; Iridium; Models, Molecular; Neoplasms; Ruthenium | 2019 |
Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC.
Topics: Cell Line, Tumor; Cell Proliferation; Chromatin; DNA Damage; DNA Repair; DNA-Binding Proteins; Humans; Neoplasms; Organometallic Compounds; Platinum; Ruthenium | 2019 |
Synthesis and Characterization of an Epidermal Growth Factor Receptor-Selective Ru
Topics: Cell Line, Tumor; ErbB Receptors; Humans; Neoplasms; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Polycyclic Compounds; Ruthenium | 2020 |
Microwave-assisted synthesis of arene ruthenium(II) complexes that induce S-phase arrest in cancer cells by DNA damage-mediated p53 phosphorylation.
Topics: Blotting, Western; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Circular Dichroism; Crystallography, X-Ray; Cyclin A; DNA Damage; Dose-Response Relationship, Drug; Humans; Hydrocarbons, Aromatic; Microwaves; Models, Chemical; Molecular Structure; Neoplasms; Organometallic Compounds; Phosphorylation; Ruthenium; S Phase; Tumor Suppressor Protein p53 | 2013 |
Transporting and shielding photosensitisers by using water-soluble organometallic cages: a new strategy in drug delivery and photodynamic therapy.
Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Coordination Complexes; Drug Carriers; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Platinum; Ruthenium; Water | 2013 |
Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(III) drug bound to holo-transferrin in simulated cancer cytosol.
Topics: Antineoplastic Agents; Ascorbic Acid; Blood Proteins; Cell Proliferation; Cytosol; Drug Design; Electrophoresis, Capillary; Glutathione; Humans; Ligands; Mass Spectrometry; Neoplasms; Oxidation-Reduction; Protein Binding; Ruthenium; Time Factors; Transferrin | 2013 |
A ruthenium(II) β-carboline complex induced p53-mediated apoptosis in cancer cells.
Topics: Animals; Apoptosis; Carbolines; Cell Proliferation; Cytochromes c; Hep G2 Cells; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Neoplasms; Ruthenium; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |
X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake.
Topics: Antineoplastic Agents; Biological Transport; Cell Adhesion; Cell Line, Tumor; Heterocyclic Compounds; Humans; Iodine; Ligands; Neoplasms; Optical Imaging; Organometallic Compounds; Quaternary Ammonium Compounds; Ruthenium; Single-Cell Analysis; X-Rays | 2013 |
Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; Humans; Membrane Potential, Mitochondrial; Neoplasms; Phenanthrolines; Phenazines; Pyridines; Reactive Oxygen Species; Ruthenium | 2013 |
A new design for nucleolipid-based Ru(III) complexes as anticancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Drug Design; Fatty Acids, Monounsaturated; Humans; Neoplasms; Phosphatidylcholines; Quaternary Ammonium Compounds; Ruthenium; Uridine | 2013 |
Biological studies of chalcogenolato-bridged dinuclear half-sandwich complexes.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Survival; Chalcogens; Coordination Complexes; DNA; Humans; Neoplasms; Ruthenium | 2013 |
Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Coordination Complexes; Fibroblast Growth Factor 2; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, SCID; Neoplasms; Oxyquinoline; Proto-Oncogene Proteins c-akt; Ruthenium; Signal Transduction | 2014 |
Production of reactive oxygen and nitrogen species by light irradiation of a nitrosyl phthalocyanine ruthenium complex as a strategy for cancer treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Indoles; Isoindoles; Light; Mice; Neoplasms; Nitric Oxide; Photochemotherapy; Pyrazines; Pyridines; Ruthenium; Singlet Oxygen | 2014 |
Synthesis, characterization, DNA binding, light switch "on and off", docking studies and cytotoxicity, of ruthenium(II) and cobalt(III) polypyridyl complexes.
Topics: Anti-Bacterial Agents; Bacteria; Cell Survival; Cobalt; DNA; Intercalating Agents; Light; Magnetic Resonance Spectroscopy; Neoplasms; Organometallic Compounds; Phenanthrolines; Pyridines; Ruthenium; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 2014 |
Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cymenes; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Molecular Conformation; Monoterpenes; Neoplasms; Organometallic Compounds; Pyridines; Ruthenium | 2014 |
pH and DNA luminescence switching, DNA photocleavage and cytotoxic properties of two thiophene-containing ruthenium(II) complexes.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Proliferation; Coordination Complexes; DNA; DNA Cleavage; Humans; Hydrogen-Ion Concentration; Light; Luminescence; Molecular Structure; Neoplasms; Organometallic Compounds; Quantum Theory; Ruthenium; Structure-Activity Relationship; Thiophenes; Tumor Cells, Cultured | 2014 |
Ruthenium (II) complexes interact with human serum albumin and induce apoptosis of tumor cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Neoplasms; Ruthenium; Serum Albumin | 2015 |
Phosphorescent ruthenium complexes with a nitroimidazole unit that image oxygen fluctuation in tumor tissue.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Coordination Complexes; Energy Transfer; Female; Green Fluorescent Proteins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Nitroimidazoles; Optical Imaging; Oxygen; Ruthenium; Transplantation, Heterologous | 2015 |
A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Drug Design; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Molecular Structure; Neoplasms; Organometallic Compounds; Radiation-Sensitizing Agents; Reactive Oxygen Species; Ruthenium; Selenium; Signal Transduction; Structure-Activity Relationship | 2015 |
The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Topics: Animals; Apoptosis; Cell Adhesion; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cisplatin; Coordination Complexes; Endocytosis; Endothelial Cells; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Mice; Microscopy, Fluorescence; Neoplasms; Neovascularization, Physiologic; Nitroimidazoles; Oxidative Stress; Pyridines; RNA, Messenger; Ruthenium; Subcellular Fractions; Wound Healing | 2015 |
Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Coordination Complexes; Crystallography, X-Ray; Cymenes; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ruthenium | 2015 |
Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; DNA Breaks, Single-Stranded; Humans; Hypoxia; Iridium; Models, Molecular; Neoplasms; Ruthenium | 2015 |
Multifunctional selenium nanoparticles: Chiral selectivity of delivering MDR-siRNA for reversal of multidrug resistance and real-time biofluorescence imaging.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Gene Transfer Techniques; Humans; Nanoparticles; Neoplasms; RNA, Small Interfering; Ruthenium; Selenium | 2015 |
Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.
Topics: Antineoplastic Agents; Cathepsin B; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Cymenes; DNA; Gold; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ruthenium | 2015 |
1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Magnetic Resonance Spectroscopy; Metabolome; Neoplasms; Organometallic Compounds; Ruthenium | 2015 |
Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; HeLa Cells; Humans; Models, Molecular; Neoplasms; Organometallic Compounds; Quinazolines; Ruthenium | 2015 |
Receptor selective ruthenium-somatostatin photosensitizer for cancer targeted photodynamic applications.
Topics: Cell Line, Tumor; Cell Survival; Coordination Complexes; Endocytosis; Humans; Microscopy, Confocal; Neoplasms; Photochemotherapy; Photosensitizing Agents; Receptors, Somatostatin; Ruthenium; Singlet Oxygen; Somatostatin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2015 |
Simultaneous realization of Hg(2+) sensing, magnetic resonance imaging and upconversion luminescence in vitro and in vivo bioimaging based on hollow mesoporous silica coated UCNPs and ruthenium complex.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; HeLa Cells; Humans; Ions; Magnetic Resonance Imaging; Mercury; Mice; Mice, Nude; Microscopy, Confocal; Nanoparticles; Neoplasms; Polyethyleneimine; Porosity; Radiography; Ruthenium; Silicon Dioxide; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Transplantation, Heterologous | 2015 |
Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Chlorides; HeLa Cells; Humans; Ligands; Neoplasms; Organometallic Compounds; Ruthenium; Water | 2015 |
Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process.
Topics: Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Humans; Molecular Structure; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Transforming Growth Factor beta1 | 2015 |
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cymenes; Female; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ovarian Neoplasms; Ruthenium; Thiazoles; Transcriptome | 2015 |
Ru(II)-polypyridyl surface functionalised gold nanoparticles as DNA targeting supramolecular structures and luminescent cellular imaging agents.
Topics: DNA, Neoplasm; Gold; HeLa Cells; Humans; Metal Nanoparticles; Neoplasms; Optical Imaging; Ruthenium | 2016 |
Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy.
Topics: Cell Survival; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Light; Micelles; Molecular Weight; Nanostructures; Neoplasms; Phototherapy; Polyethylene Glycols; Polymers; Prodrugs; Ruthenium | 2016 |
Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis, Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent.
Topics: Antineoplastic Agents; Benzothiazoles; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Free Radical Scavengers; Heterocyclic Compounds; Humans; Ligands; Neoplasms; Picrates; Ruthenium; Schiff Bases; Sulfonic Acids | 2016 |
Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Neoplasms; Reactive Oxygen Species; Ruthenium | 2016 |
Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Coordination Complexes; Drug Discovery; Humans; Neoplasms; Ruthenium | 2016 |
Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Nitric Oxide; Nitrogen Oxides; Ruthenium; Sulfhydryl Compounds | 2016 |
Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; Humans; Molecular Docking Simulation; Neoplasms; Phenanthrolines; Ruthenium; Topoisomerase II Inhibitors | 2016 |
In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
Topics: Animals; Antineoplastic Agents; Cattle; Coordination Complexes; Cricetinae; DNA; Female; HeLa Cells; Hep G2 Cells; Humans; MCF-7 Cells; Mice; Neoplasms; Ruthenium; Serum Albumin, Bovine | 2016 |
Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Binding, Competitive; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Circular Dichroism; Coordination Complexes; DNA; Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; G-Quadruplexes; HeLa Cells; Hep G2 Cells; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Neoplasms; Reactive Oxygen Species; Ruthenium; Spectrophotometry; Time Factors | 2016 |
Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Clioquinol; Cymenes; Enzyme Inhibitors; Humans; Monoterpenes; Neoplasm Invasiveness; Neoplasms; Organometallic Compounds; Ruthenium | 2016 |
An Amphiphilic Ruthenium Polymetallodrug for Combined Photodynamic Therapy and Photochemotherapy In Vivo.
Topics: Animals; Light; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Ruthenium | 2017 |
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Endoplasmic Reticulum Stress; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; HCT116 Cells; Histones; Humans; Neoplasms; Organometallic Compounds; Ruthenium | 2017 |
Ruthenium(II) Complex Incorporated UiO-67 Metal-Organic Framework Nanoparticles for Enhanced Two-Photon Fluorescence Imaging and Photodynamic Cancer Therapy.
Topics: Fluorescence; Humans; Metal Nanoparticles; Metal-Organic Frameworks; Neoplasms; Ruthenium | 2017 |
Long Blood Residence and Large Tumor Uptake of Ruthenium Sulfide Nanoclusters for Highly Efficient Cancer Photothermal Therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Hyperthermia, Induced; Metal Nanoparticles; Mice; Neoplasms; Phototherapy; Polyethylene Glycols; Ruthenium; Tissue Distribution; Xenograft Model Antitumor Assays | 2017 |
Preface.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Coordination Complexes; Drug Discovery; Heterocyclic Compounds; Humans; Neoplasms; Ruthenium | 2017 |
Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: trackable NO donors for light-triggered NO delivery to cellular targets.
Topics: Cell Line, Tumor; Fluorescent Dyes; Humans; Light; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Organometallic Compounds; Oxazines; Photochemotherapy; Photolysis; Ruthenium; Skin Neoplasms | 2008 |
Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; DNA; DNA, Superhelical; Guanine; Humans; Neoplasms; Nucleic Acid Denaturation; Organometallic Compounds; Ruthenium; Spectrum Analysis; Structure-Activity Relationship; Terphenyl Compounds | 2008 |
Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy.
Topics: Antineoplastic Agents; Calixarenes; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Humans; Light; Metalloporphyrins; Molecular Structure; Neoplasms; Photosensitizing Agents; Ruthenium; Time Factors; Tumor Cells, Cultured | 2009 |
Metal complexes as photochemical nitric oxide precursors: potential applications in the treatment of tumors.
Topics: Chromium; Coordination Complexes; Energy Transfer; Fluorescence Resonance Energy Transfer; Humans; Iron; Neoplasms; Nitric Oxide; Nitroso Compounds; Photochemical Processes; Quantum Dots; Radiation-Sensitizing Agents; Ruthenium | 2009 |
The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Gold; Humans; Mice; Neoplasms; Platinum; Ruthenium; Thiocarbamates | 2009 |
Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Neoplasms; Organometallic Compounds; Ruthenium | 2010 |
Use of perfluorinated phosphines to provide thermomorphic anticancer complexes for heat-based tumor targeting.
Topics: Antineoplastic Agents; Cell Line, Tumor; Halogenation; Hot Temperature; Humans; Inhibitory Concentration 50; Neoplasms; Organometallic Compounds; Phosphines; Ruthenium; Solubility; Water | 2010 |
Bio-bar-code dendrimer-like DNA as signal amplifier for cancerous cells assay using ruthenium nanoparticle-based ultrasensitive chemiluminescence detection.
Topics: Biosensing Techniques; Cell Line, Tumor; Dendrimers; DNA; Electrophoresis, Agar Gel; Humans; Luminescent Agents; Luminescent Measurements; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Neoplasms; Ruthenium; Surface Properties | 2010 |
Noncovalent DNA-binding metallo-supramolecular cylinders prevent DNA transactions in vitro.
Topics: Coordination Complexes; DNA; DNA Replication; Humans; Iron; Ligands; Neoplasms; Ruthenium; Taq Polymerase | 2010 |
Dye-tethered ruthenium nitrosyls containing planar dicarboxamide tetradentate N4 ligands: effects of in-plane ligand twist on NO photolability.
Topics: Benzene; Crystallography, X-Ray; Fluorescent Dyes; Ligands; Light; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Nitric Oxide; Nitroso Compounds; Oxazines; Photochemistry; Photolysis; Pyridines; Ruthenium | 2011 |
Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Neoplasms; Ruthenium | 2011 |
Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex.
Topics: Antineoplastic Agents; Binding Sites; DNA; Drug Delivery Systems; Humans; Neoplasms; Octreotide; Oligopeptides; Organometallic Compounds; Photochemical Processes; Ruthenium | 2011 |
Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Ethylenediamines; Humans; Ligands; Neoplasms; Ruthenium; Stereoisomerism; Structure-Activity Relationship | 2011 |
From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects?
Topics: Antineoplastic Agents; Catalysis; Cell Line, Tumor; Cell Survival; Coordination Complexes; Drug Design; Enzyme Inhibitors; Enzymes; Humans; Neoplasms; Organometallic Compounds; Ruthenium | 2011 |
Synthesis of glycoconjugate carbonic anhydrase inhibitors by ruthenium-catalysed azide-alkyne 1,3-dipolar cycloaddition.
Topics: Alkynes; Antineoplastic Agents; Azides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalysis; Cell Line, Tumor; Cyclization; Glycoconjugates; Humans; Neoplasms; Ruthenium | 2011 |
Efficient oxidation of cysteine and glutathione catalyzed by a dinuclear areneruthenium trithiolato anticancer complex.
Topics: Antineoplastic Agents; Catalysis; Cysteine; Disulfides; Glutathione; Magnetic Resonance Spectroscopy; Neoplasms; Organometallic Compounds; Oxidation-Reduction; Ruthenium | 2011 |
Efficient photodynamic therapy of cancer using chemotherapeutic porphyrin-ruthenium metalla-cubes.
Topics: Antineoplastic Agents; Cations; Cell Line, Tumor; Dose-Response Relationship, Radiation; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Light; Melanoma; Metals; Models, Chemical; Neoplasms; Ovarian Neoplasms; Photochemistry; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ruthenium; Time Factors | 2012 |
Ruthenium-based complex nanocarriers for cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Stability; Humans; Liposomes; Materials Testing; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Organometallic Compounds; Rats; Ruthenium | 2012 |
Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(II) mixed-ligand complexes.
Topics: 2,2'-Dipyridyl; Animals; Antineoplastic Agents; Cattle; Cell Survival; Coordination Complexes; DNA; HeLa Cells; Hep G2 Cells; Humans; Ligands; Models, Molecular; Neoplasms; Phenanthrolines; Ruthenium; Spectrum Analysis | 2012 |
Strained ruthenium complexes are potent light-activated anticancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; Humans; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium | 2012 |
Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; DNA Damage; Histones; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Pyridines; Ruthenium; Tumor Suppressor Protein p53 | 2012 |
Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis induction.
Topics: Antineoplastic Agents; Apoptosis; Curcumin; DNA; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Neoplasms; Oxidative Stress; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Ruthenium | 2012 |
Heterodinuclear ruthenium(II)-cobalt(III) complexes as models for a new approach to selective cancer treatment.
Topics: Antineoplastic Agents; Cobalt; Coordination Complexes; Crystallography, X-Ray; Drug Delivery Systems; Electron Transport; Humans; Light; Models, Molecular; Neoplasms; Oxidation-Reduction; Phenanthrolines; Pyridines; Ruthenium | 2012 |
INTRAGASTRIC BETA-IRRADIATION WITH RUTHENIUM- RHODIUM106 IN PATIENTS WITH PEPTIC ULCER AND GASTRIC NEOPLASM.
Topics: Humans; Neoplasms; Peptic Ulcer; Rhodium; Ruthenium; Stomach Neoplasms; Stomach Ulcer | 1963 |
CARCINOMA OF THE LUNG IN RATS EXPOSED TO THE BETA-RADIATION OF INTRABRONCHIAL RUTHENIUM PELLETS. I. DOSERESPONSE RELATIONSHIPS.
Topics: Animals; Carcinoma; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Radiation-Induced; Research; Ruthenium | 1963 |
TISSUE REACTIONS AND DOSE RELATIONSHIPS IN RATS FOLLOWING INTRAPULMONARY BETA RADIATION.
Topics: Beta Particles; Carcinoma, Squamous Cell; Lung Neoplasms; Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Pathology; Phosphorus Isotopes; Radiometry; Rats; Research; Ruthenium | 1964 |
INHIBITION OF LANDSCHUETZ ASCITES TUMOUR GROWTH BY METAL CHELATES DERIVED FROM 3,4,7,8-TETRAMETHYL-1,10-PHENANTHROLINE.
Topics: Animals; Antineoplastic Agents; Ascites; Copper; Metals; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenanthrolines; Research; Ruthenium | 1965 |
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
Topics: Animals; Cell Line, Tumor; Collagen; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Combinations; Inhibitory Concentration 50; Kidney; Laminin; Ligands; Liver; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Inbred CBA; Models, Chemical; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Organometallic Compounds; Proteoglycans; Ruthenium; Ruthenium Compounds; Tissue Distribution | 2004 |
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A.
Topics: Actin Cytoskeleton; Antibodies, Blocking; Antineoplastic Agents; Cell Adhesion; Cell Line; Dimethyl Sulfoxide; HeLa Cells; Humans; Integrins; Microscopy, Confocal; Microscopy, Electron, Scanning; Neoplasms; Neutrophils; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Trypsin | 2004 |
Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins--significance for the patient.
Topics: Albumins; Antineoplastic Agents; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Humans; Indazoles; Neoplasms; Organometallic Compounds; Protein Binding; Ruthenium; Ruthenium Compounds; Spectrometry, Mass, Electrospray Ionization; Transferrin | 2005 |
Radioactive ruthenium red accumulation by tumors: a potential scanning agent.
Topics: Animals; Binding Sites; Carcinoma, Hepatocellular; Coloring Agents; Glycosaminoglycans; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Radionuclide Imaging; Rats; Ruthenium | 1975 |
[Tumor affinity of 103 Ru-ruthenocen-derivatives and 67gallium citrate].
Topics: Animals; Carcinoma, Ehrlich Tumor; Gallium Radioisotopes; Mice; Neoplasms; Radioisotopes; Radionuclide Imaging; Ruthenium | 1978 |
[Electron microscopy demonstration of sulphurated acid mucopolysaccharides in canine mast cell tumors, using barium chloride and ruthenium red, together with comments on the classification and differentiation of tumor cells].
Topics: Animals; Barium; Chlorides; Dog Diseases; Dogs; Female; Glycosaminoglycans; Histocytochemistry; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mast-Cell Sarcoma; Microscopy, Electron; Neoplasms; Ruthenium; Skin Neoplasms; Splenic Neoplasms; Staining and Labeling | 1971 |